PT2323644E - Derivados de benzenopropanamida ou benzenopropenamida, substituídos em n, com utilização no tratamento da dor - Google Patents

Derivados de benzenopropanamida ou benzenopropenamida, substituídos em n, com utilização no tratamento da dor Download PDF

Info

Publication number
PT2323644E
PT2323644E PT97177737T PT09717773T PT2323644E PT 2323644 E PT2323644 E PT 2323644E PT 97177737 T PT97177737 T PT 97177737T PT 09717773 T PT09717773 T PT 09717773T PT 2323644 E PT2323644 E PT 2323644E
Authority
PT
Portugal
Prior art keywords
benzenepropenamide
benzenepropanamide
pain
derivatives
substituted
Prior art date
Application number
PT97177737T
Other languages
English (en)
Portuguese (pt)
Inventor
Eliahu Kaplan
Original Assignee
Novaremed Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novaremed Ltd filed Critical Novaremed Ltd
Publication of PT2323644E publication Critical patent/PT2323644E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/90—Carboxylic acid amides having nitrogen atoms of carboxamide groups further acylated
    • C07C233/91—Carboxylic acid amides having nitrogen atoms of carboxamide groups further acylated with carbon atoms of the carboxamide groups bound to acyclic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F3/00—Compounds containing elements of Groups 2 or 12 of the Periodic Table
    • C07F3/003—Compounds containing elements of Groups 2 or 12 of the Periodic Table without C-Metal linkages

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Polyethers (AREA)
PT97177737T 2008-03-06 2009-03-06 Derivados de benzenopropanamida ou benzenopropenamida, substituídos em n, com utilização no tratamento da dor PT2323644E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0804213.7A GB0804213D0 (en) 2008-03-06 2008-03-06 A method of printing or preventing pain

Publications (1)

Publication Number Publication Date
PT2323644E true PT2323644E (pt) 2014-07-25

Family

ID=39327664

Family Applications (1)

Application Number Title Priority Date Filing Date
PT97177737T PT2323644E (pt) 2008-03-06 2009-03-06 Derivados de benzenopropanamida ou benzenopropenamida, substituídos em n, com utilização no tratamento da dor

Country Status (12)

Country Link
US (2) US8883853B2 (enExample)
EP (1) EP2323644B1 (enExample)
JP (1) JP5657394B2 (enExample)
AU (1) AU2009220931B2 (enExample)
CA (1) CA2717692C (enExample)
DK (1) DK2323644T3 (enExample)
ES (1) ES2505325T3 (enExample)
GB (1) GB0804213D0 (enExample)
IL (1) IL207965A (enExample)
PL (1) PL2323644T3 (enExample)
PT (1) PT2323644E (enExample)
WO (1) WO2009109850A2 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4939396B2 (ja) 2004-03-26 2012-05-23 ノヴァレメッド リミテッド Ａｉｄｓ及び他のウイルス性疾患及びｈｉｖ関連感染症の改善又はその治療用化合物及びそのような化合物を含む組成物、そのような疾患及び感染症の治療方法及びそのような化合物及び組成物の製造方法
GB0804213D0 (en) 2008-03-06 2008-04-16 New Era Biotech Ltd A method of printing or preventing pain
US8802734B2 (en) 2009-09-09 2014-08-12 Novaremed Limited Method of treating or preventing pain
CN102821761B (zh) * 2009-09-09 2015-06-10 诺瓦麦有限公司 用于治疗疼痛和炎症的n-取代的苯丙酰胺或苯丙烯酰胺
GB201116335D0 (en) * 2011-09-21 2011-11-02 Novaremed Ltd A method of treating or preventing affective disorders
AU2012348529B2 (en) * 2011-12-08 2017-03-30 Novaremed Ltd. Isolated stereoisomeric forms of (S) 2-N (3-O-(propan 2-ol) -1-propyl-4-hydroxybenzene) -3-phenylpropylamide
SG11202111773QA (en) 2019-01-23 2021-11-29 Novaremed Ltd Compounds for use in the treatment or prophylaxis of pain, inflammation and/or autoimmunity
EP3939578A1 (en) 2020-07-13 2022-01-19 Novaremed Ltd. Compounds for treatment or prevention of an infection resulting from a coronavirus and/or a coronavirus-induced disease

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2908691A (en) * 1958-07-14 1959-10-13 Searle & Co Hydroxyphenalkylaminoalkylindoles and ethers corresponding thereto
GB1037655A (en) * 1964-05-20 1966-08-03 Koninklijke Pharma Fab Nv Di(aralkyl)amines
ZA732136B (en) 1972-04-12 1974-03-27 Lilly Co Eli Dopamine derivatives
JPS5236606A (en) 1975-09-12 1977-03-22 Tanabe Seiyaku Co Ltd Process for preparation of amino compounds
US4766106A (en) * 1985-06-26 1988-08-23 Cetus Corporation Solubilization of proteins for pharmaceutical compositions using polymer conjugation
US4908322A (en) * 1985-09-06 1990-03-13 The United States Of America As Represented By The Department Of Health And Human Services Derivatization of amines for electrochemical detection
US5696270A (en) * 1989-05-23 1997-12-09 Abbott Laboratories Intermediate for making retroviral protease inhibiting compounds
IS2334B (is) * 1992-09-08 2008-02-15 Vertex Pharmaceuticals Inc., (A Massachusetts Corporation) Aspartyl próteasi hemjari af nýjum flokki súlfonamíða
JP2848232B2 (ja) 1993-02-19 1999-01-20 武田薬品工業株式会社 アルデヒド誘導体
AU1463997A (en) * 1995-12-22 1997-07-17 Acea Pharmaceuticals, Inc. Subtype-selective nmda receptor ligands and the use thereof
WO1997029079A1 (en) 1996-02-06 1997-08-14 Japan Tobacco Inc. Novel compounds and pharmaceutical use thereof
JP2941230B2 (ja) * 1997-05-06 1999-08-25 コナミ株式会社 画像表示処理装置，画像表示処理方法，及びコンピュータプログラムを記録した機械読取り可能な記録媒体
AU2002224139A1 (en) 2000-12-05 2002-06-18 Nippon Chemiphar Co. Ltd. Ppar (peroxisome proliferator activated receptor) activators
JP4667870B2 (ja) * 2002-10-03 2011-04-13 ノヴァレメッド リミテッド 自己免疫疾患、免疫−アレルギー疾患及び臓器又は組織移植拒絶反応の治療において使用する新規な化合物
WO2004047743A2 (en) * 2002-11-22 2004-06-10 Bristol-Myers Squibb Company 1-aryl-2-hydroxyethyl amides as potassium channel openers
JP4939396B2 (ja) * 2004-03-26 2012-05-23 ノヴァレメッド リミテッド Ａｉｄｓ及び他のウイルス性疾患及びｈｉｖ関連感染症の改善又はその治療用化合物及びそのような化合物を含む組成物、そのような疾患及び感染症の治療方法及びそのような化合物及び組成物の製造方法
DE102004039373A1 (de) * 2004-08-12 2006-02-23 Grünenthal GmbH Para-Alkyl-substituierte N-(4-Hydroxy-3-methoxy-benzyl)-zimtsäureamide und deren Verwendung zur Herstellung von Arzneimitteln
RU2309144C2 (ru) * 2005-03-25 2007-10-27 Общество С Ограниченной Ответственностью "Фарминтерпрайсез" Фенилсодержащие n-ацильные производные аминов, способ их получения, фармацевтическая композиция и их применение в качестве противовоспалительных и анальгетических средств
PL2026775T3 (pl) 2006-05-09 2015-12-31 Novaremed Ltd Zastosowanie inhibitorów kinazy tyrozynowej Syk w leczeniu komórkowych zaburzeń proliferacyjnych
WO2009039218A2 (en) 2007-09-17 2009-03-26 Chi-Huey Wong Compositions and methods for treating inflammation and inflammation-related disorders by plectranthus amboinicus extracts
GB0804213D0 (en) 2008-03-06 2008-04-16 New Era Biotech Ltd A method of printing or preventing pain
CN101503370B (zh) 2009-03-02 2012-08-22 上海应用技术学院 一种n-环丙基-反-2-顺-6-壬二烯酸酰胺的合成方法
CN101503373B (zh) 2009-03-13 2013-07-24 山东大学 2-氨基-1-(4-硝基苯基)-1-乙醇类金属蛋白酶抑制剂及其制备方法和用途
US8802734B2 (en) * 2009-09-09 2014-08-12 Novaremed Limited Method of treating or preventing pain

Also Published As

Publication number Publication date
US8883853B2 (en) 2014-11-11
AU2009220931A1 (en) 2009-09-11
EP2323644A2 (en) 2011-05-25
PL2323644T3 (pl) 2014-10-31
IL207965A0 (en) 2010-12-30
AU2009220931B2 (en) 2014-11-13
WO2009109850A2 (en) 2009-09-11
GB0804213D0 (en) 2008-04-16
CA2717692A1 (en) 2009-09-11
DK2323644T3 (da) 2014-07-21
US20110039936A1 (en) 2011-02-17
WO2009109850A3 (en) 2009-12-10
CA2717692C (en) 2016-06-07
US9199917B2 (en) 2015-12-01
JP2011513377A (ja) 2011-04-28
IL207965A (en) 2015-10-29
JP5657394B2 (ja) 2015-01-21
EP2323644B1 (en) 2014-04-23
ES2505325T3 (es) 2014-10-09
US20150080473A1 (en) 2015-03-19

Similar Documents

Publication Publication Date Title
IL210810A0 (en) Compositions for the treatment of pain and/or inflamtion
GB0610867D0 (en) Treatment of pain
IL210856A0 (en) Combination therapy for the treatment of diabetes and related conditions
ZA200907137B (en) Novel N-(8-heteroaryltetrahydronaphtalene-2yl) or N-(5-heteroarylchromane-3-yl) carboxamide derivatives for the treatment of pain
IL193748A0 (en) Treatment of pain
IL218143A0 (en) Substituted heterocyclic derivatives for the treatment of pain and epilepsy
ZA201002764B (en) Benzodiazepinone compounds useful in the treatment of skin conditions
IL205578A0 (en) Aldh-2 inhibitors in the treatment of psychiatric disorders
PT2323644E (pt) Derivados de benzenopropanamida ou benzenopropenamida, substituídos em n, com utilização no tratamento da dor
ZA201101424B (en) Aminophosphinic derivatives that can be used in the treatment of pain
IL218851A0 (en) Use of dimiracetam in the treatment of chronic pain
IL207127A0 (en) Aldh-2 inhibitors in the treatment of addiction
IL210290A0 (en) Use of pyrimidylaminobenzamide derivatives for the treatment of fibrosis
GB0822486D0 (en) Compounds for use in the treatment of pain
IL213703A (en) Compounds for the treatment of pain and other diseases
IL204668A0 (en) Use of sulfonyl - substituted 2 - sulfonylaminobenzoic acid n - phenylamides in the treatment of pain
IL206107A0 (en) Alpha-aminoamide derivatives useful in the treatment of psychiatric disorders
ZA201108106B (en) Use of phthalimide derivatives in the treatment of diseases
IL192933A0 (en) Benzoisoindole derivatives for the treatment of pain
PT2475361T (pt) Derivados de benzenopropanamidas substituídas em n, para serem utilizadas no tratamento de dor e de inflamação
EP2124950A4 (en) PAIN TREATMENT WITH NALOXONE
EP2246055A4 (en) USE OF ARYLPIPERAZINE DERIVATIVES IN THE MANUFACTURE OF ANALGETICS
GB0610868D0 (en) Treatment of pain
ZA201103134B (en) (pyrrolidin-2 yl) phenyl derivatives for use in the treatment of pain
GB0616450D0 (en) Treatment of pain